Curanex Pharmaceuticals Inc Common Stock Financial Flexibility Index
Curanex Pharmaceuticals Inc Common Stock financial flexibility index. Curanex Pharmaceuticals Inc Common Stock (CURX) has a Financial Flexibility Index of -49.40x as of September 2025. Free cash flow of $-9.19 Million (operating CF $-9.19 Million minus capex $0.00) represents -49% of total liabilities ($185.96K). See Curanex Pharmaceuticals Inc Common Stock free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Curanex Pharmaceuticals Inc Common Stock (2023–2024)
Financial flexibility index of Curanex Pharmaceuticals Inc Common Stock from 2023 to 2024. Historical Financial Flexibility Index trend for Curanex Pharmaceuticals Inc Common Stock across 2 annual periods. Explore Curanex Pharmaceuticals Inc Common Stock cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Curanex Pharmaceuticals Inc Common Stock Financial Flexibility Index by Year (2023–2024)
Curanex Pharmaceuticals Inc Common Stock financial flexibility index by year from 2023 to 2024. Year-by-year free cash flow to debt coverage for Curanex Pharmaceuticals Inc Common Stock. For the full cash flow conversion analysis, see cash flow conversion of Curanex Pharmaceuticals Inc Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -38.12x | $-555.57K | $-555.58K | $14.57K | ▼ -453377.3% |
| 2023 | -0.01x | $-120.00 | $-120.00 | $14.28K | — |